| Monograph Title
|
Monograph Section
|
Scientific Liaison
|
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Title | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Definition | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Packaging and storage | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | USP Reference standards <11> | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Identification | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Dissolution, Method B <711> | Margareth Marques |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Uniformity of dosage units <905> | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Water, Method Ia <921> | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Related compounds | Ahalya Wise |
| DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS PF 34(3) Pg. 589 | Assay | Ahalya Wise |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Title | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Definition | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Packaging and storage | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | USP Reference standards <11> | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Identification | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Bacterial endotoxins <85> | Radha Tirumalai |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Sterility <71> | Radha Tirumalai |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | pH <791> | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Particulate matter <788> | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Osmolality <785> | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Related compounds | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Benzyl alcohol content (if present) | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Other requirements | Sujatha Ramakrishna |
| ENALAPRILAT INJECTION PF 34(3) Pg. 593 | Assay | Sujatha Ramakrishna |
| ESTRADIOL TABLETS PF 34(3) Pg. 596 | USP Reference standards <11> | Ahalya Wise |
| ESTRADIOL TABLETS PF 34(3) Pg. 596 | Chromatographic purity | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Title | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Definition | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Packaging and storage | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | USP Reference standards | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Identification A, B | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Loss on drying | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Chromatographic purity | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 31(6) Pg. 1617 | Assay | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Title | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Definition | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Packaging and storage | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Identification | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Microbial limits <61> | Radha Tirumalai |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Loss on drying <731> | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Chromatographic purity | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 32(4) Pg. 1071 | Assay | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | Packaging and storage | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | USP Reference standards <11> | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | Identification | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | Dissolution <711> | Margareth Marques |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | Loss on drying <731> | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | Chromatographic purity | Ahalya Wise |
| ESTRADIOL VAGINAL INSERTS PF 34(3) Pg. 597 | Assay | Ahalya Wise |
| FENOFIBRATE CAPSULES PF 34(2) Pg. 258 | Dissolution <711> | Margareth Marques |
| FENOPROFEN CALCIUM PF 34(3) Pg. 601 | Chromatographic purity | Clyde Anthony |
| FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDEDRELEASE TABLETS PF 34(2) Pg. 262 | Identification | Ahalya Wise |
| FLAVOXATE HYDROCHLORIDE TABLETS PF 34(3) Pg. 607 | Dissolution <711> | Margareth Marques |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Title | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Definition | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Packaging and storage | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Labeling | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | USP Reference standards <11> | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Identification | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Bacterial endotoxins <85> | Radha Tirumalai |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Sterility <71> | Radha Tirumalai |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Other requirements | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Related compounds | Behnam Davani |
| FLUCONAZOLE INJECTION PF 34(2) Pg. 266 | Assay | Behnam Davani |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Title | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Definition | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Packaging and storage | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | USP Reference standards <11> | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Identification | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Microbial limits <61> | Radha Tirumalai |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | pH <791> | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Minimum fill <755> | Ahalya Wise |
| FLUTICASONE PROPIONATE CREAM PF 34(3) Pg. 609 | Assay | Ahalya Wise |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | Title | Ahalya Wise |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | Definition | Ahalya Wise |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | Packaging and storage | Ahalya Wise |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | USP Reference standards <11> | Ahalya Wise |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | Identification | Ahalya Wise |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | Microbial limits <61> | Radha Tirumalai |
| FLUTICASONE PROPIONATE OINTMENT PF 34(3) Pg. 611 | Assay | Ahalya Wise |
| FOSINOPRIL SODIUM PF 34(3) Pg. 613 | Related compounds | Sujatha Ramakrishna |
| FOSPHENYTOIN SODIUM PF 34(2) Pg. 270 | Related compounds | Ravi Ravichandran |
| FOSPHENYTOIN SODIUM PF 34(2) Pg. 270 | Assay | Ravi Ravichandran |
| GLUCOSAMINE HYDROCHLORIDE PF 33(4) Pg. 691 | Assay | Curtis Phinney |
| GLUCOSAMINE SULFATE POTASSIUM CHLORIDE PF 33(4) Pg. 692 | Assay | Curtis Phinney |
| GLUCOSAMINE SULFATE SODIUM CHLORIDE PF 33(4) Pg. 692 | Assay | Curtis Phinney |
| GLYBURIDE TABLETS PF 33(4) Pg. 651 | Dissolution <711> | Margareth Marques |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Title | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Chemical Info | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Definition | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Packaging and storage | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | USP Reference standards <11> | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Identification | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Loss on drying <731> | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Residue on ignition <281> | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Heavy metals, Method II <231> | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Related compounds | Ravi Ravichandran |
| HALOPERIDOL DECANOATE PF 34(3) Pg. 614 | Assay | Ravi Ravichandran |
| HIGH FRUCTOSE CORN SYRUP PF 34(2) Pg. 329 | Total solids | Hong Wang |
| HIGH FRUCTOSE CORN SYRUP PF 34(2) Pg. 329 | Assay | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Title | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Chemical Info | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Definition | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Packaging and storage | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Identification | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Melting range <741> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Acid value, Method II <401> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Peroxide value <401> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Unsaponifiable matter <401> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Fatty acid composition | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Loss on drying <731> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Residue on ignition <281> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Heavy metals, Method II <231> | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Alkaline impurities | Hong Wang |
| HYDROGENATED COCONUT OIL PF 34(2) Pg. 327 | Limit of nickel | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Title | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Chemical Info | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Definition | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Packaging and storage | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Identification | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Melting range <741> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Acid value, Method II <401> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Peroxide value <401> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Unsaponifiable matter <401> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Fatty acid composition | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Loss on drying <731> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Residue on ignition <281> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Heavy metals, Method II <231> | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Alkaline impurities | Hong Wang |
| HYDROGENATED PALM OIL PF 34(2) Pg. 330 | Limit of nickel | Hong Wang |
| HYDROXYZINE PAMOATE CAPSULES PF 34(2) Pg. 272 | Identification | Ravi Ravichandran |
| HYDROXYZINE PAMOATE CAPSULES PF 34(2) Pg. 272 | Assay | Ravi Ravichandran |
| HYDROXYZINE PAMOATE ORAL SUSPENSION PF 34(2) Pg. 273 | Identification | Ravi Ravichandran |
| HYDROXYZINE PAMOATE ORAL SUSPENSION PF 34(2) Pg. 273 | Assay | Ravi Ravichandran |
| HYDROXYZINE PAMOATE PF 34(2) Pg. 271 | Identification | Ravi Ravichandran |
| HYDROXYZINE PAMOATE PF 34(2) Pg. 271 | Residue on ignition <281> | Ravi Ravichandran |
| HYDROXYZINE PAMOATE PF 34(2) Pg. 271 | Heavy metals, Method II <231> | Ravi Ravichandran |
| HYDROXYZINE PAMOATE PF 34(2) Pg. 271 | Assay | Ravi Ravichandran |
| ISOTRETINOIN CAPSULES PF 34(2) Pg. 274 | Chromatographic purity | Feiwen Mao |
| ISOTRETINOIN CAPSULES PF 34(2) Pg. 274 | Assay | Feiwen Mao |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Title | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Definition | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Packaging and storage | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Labeling | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | USP Reference standards <11> | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Identification | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Microbial limits <61> | Radha Tirumalai |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Uniformity of dosage units <905> | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | pH <791> | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Assay for ivermectin | Elena Gonikberg |
| IVERMECTIN AND PYRANTEL PAMOATE TABLETS PF 34(2) Pg. 277 | Assay for pyrantel pamoate | Elena Gonikberg |
| KETOPROFEN PF 34(3) Pg. 617 | USP Reference standards <11> | Clyde Anthony |
| KETOPROFEN PF 34(3) Pg. 617 | Chromatographic purity | Clyde Anthony |
| LAMOTRIGINE PF 34(3) Pg. 617 | Title | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Chemical Info | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Definition | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Packaging and storage | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | USP Reference standards <11> | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Identification | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Loss on drying <731> | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Residue on ignition <281> | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Heavy metals, Method II <231> | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Limit of lamotrigine related compound B | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Related compounds | Ravi Ravichandran |
| LAMOTRIGINE PF 34(3) Pg. 617 | Assay | Ravi Ravichandran |
| LEVONORGESTREL PF 34(3) Pg. 620 | USP Reference standards <11> | Ahalya Wise |
| LEVONORGESTREL PF 34(3) Pg. 620 | Chromatographic purity | Ahalya Wise |
| LEVONORGESTREL PF 34(3) Pg. 620 | Assay | Ahalya Wise |
| LEVORPHANOL TARTRATE PF 34(2) Pg. 280 | Assay | Clyde Anthony |
| LIPID INJECTABLE EMULSION PF 34(3) Pg. 621 | Definition | Desmond Hunt |
| LIPID INJECTABLE EMULSION PF 34(3) Pg. 621 | Globule size limits | Desmond Hunt |
| LIPID INJECTABLE EMULSION PF 34(3) Pg. 621 | Limit of free fatty acid | Desmond Hunt |
| LOSARTAN POTASSIUM PF 34(3) Pg. 626 | Limit of cyclohexane and isopropyl alcohol | Sujatha Ramakrishna |
| MAFENIDE ACETATE CREAM PF 34(2) Pg. 280 | Identification | Behnam Davani |
| MAFENIDE ACETATE FOR TOPICAL SOLUTION PF 34(3) Pg. 627 | Content of acetic acid | Behnam Davani |
| MECLOCYCLINE SULFOSALICYLATE CREAM PF 34(3) Pg. 628 | Assay | Ahalya Wise |
| MECLOCYCLINE SULFOSALICYLATE PF 34(3) Pg. 627 | Assay | Ahalya Wise |
| MEFENAMIC ACID PF 34(2) Pg. 281 | Heavy metals, Method II<231> | Clyde Anthony |
| METHACHOLINE CHLORIDE PF 34(3) Pg. 629 | Identification | Ravi Ravichandran |
| METHACHOLINE CHLORIDE PF 34(3) Pg. 629 | Melting range <741> | Ravi Ravichandran |
| METHOTREXATE PF 34(3) Pg. 630 | USP Reference standards <11> | Feiwen Mao |
| METHOTREXATE PF 34(3) Pg. 630 | Chromatographic purity | Feiwen Mao |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Definition | Behnam Davani |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Packaging and storage | Behnam Davani |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | USP Reference standards <11> | Behnam Davani |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Identification | Behnam Davani |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Dissolution <711> | Margareth Marques |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Uniformity of dosage units <905> | Behnam Davani |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Related compounds | Behnam Davani |
| METRONIDAZOLE CAPSULES PF 34(3) Pg. 633 | Assay | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Packaging and storage | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | USP Reference standards <11> | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Identification | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Melting range <741> | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Non-basic substances | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Chromatographic purity | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Related compounds | Behnam Davani |
| METRONIDAZOLE PF 34(3) Pg. 631 | Assay | Behnam Davani |
| MIDAZOLAM INJECTION PF 34(3) Pg. 635 | Bacterial endotoxins <85> | Radha Tirumalai |
| MUPIROCIN CREAM PF 34(2) Pg. 281 | Related compounds | Ahalya Wise |
| MUPIROCIN CREAM PF 34(2) Pg. 281 | Assay | Ahalya Wise |
| NALTREXONE HYDROCHLORIDE PF 34(2) Pg. 283 | Related compounds | Clyde Anthony |
|
